CannaPharmaRx Financial Statements From 2010 to 2024
| CPMD Stock | USD 0.01 0.0002 2.56% |
Check CannaPharmaRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CannaPharmaRx's main balance sheet or income statement drivers, such as , as well as many indicators such as . CannaPharmaRx financial statements analysis is a perfect complement when working with CannaPharmaRx Valuation or Volatility modules.
CannaPharmaRx |
CannaPharmaRx Company Shares Outstanding Analysis
CannaPharmaRx's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current CannaPharmaRx Shares Outstanding | 257.57 M |
Most of CannaPharmaRx's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CannaPharmaRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, CannaPharmaRx has 257.57 M of shares currently outstending. This is 42.67% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 54.96% higher than that of the company.
CannaPharmaRx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CannaPharmaRx's current stock value. Our valuation model uses many indicators to compare CannaPharmaRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CannaPharmaRx competition to find correlations between indicators driving CannaPharmaRx's intrinsic value. More Info.CannaPharmaRx is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CannaPharmaRx's earnings, one of the primary drivers of an investment's value.About CannaPharmaRx Financial Statements
CannaPharmaRx stakeholders use historical fundamental indicators, such as CannaPharmaRx's revenue or net income, to determine how well the company is positioned to perform in the future. Although CannaPharmaRx investors may analyze each financial statement separately, they are all interrelated. For example, changes in CannaPharmaRx's assets and liabilities are reflected in the revenues and expenses on CannaPharmaRx's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CannaPharmaRx. Please read more on our technical analysis and fundamental analysis pages.
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. The company was incorporated in 1998 and is based in Calgary, Canada. Cannapharmarx operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CannaPharmaRx Pink Sheet
CannaPharmaRx financial ratios help investors to determine whether CannaPharmaRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CannaPharmaRx with respect to the benefits of owning CannaPharmaRx security.